Superworth

Boston Scientific forward PE BSX

Share price divided by analysts' consensus earnings for the next twelve months, since 1996.

Today, Nov 3, 2026
13.4×
10-year median
25.6×
Against its 10-year history
1st
percentile: 0 is its lowest day, 100 its highest
10-year range
13.0× to 46.9×
Peer median
19.1×

Boston Scientific's forward PE is 13.4× as of Nov 3, 2026.

That is below its ten-year median of 25.6×, lower than on 99% of days in the last ten years.

Over that time it ranged from 13.0× in Oct 2026 to 46.9× in Feb 2020.

The median for 7 medical device stocks of a similar size is 19.1×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far13.7×13.0×31.0×
202530.5×29.4×37.0×
202432.7×26.5×33.3×
202326.3×22.5×27.2×
202224.7×20.4×26.6×
202125.2×22.8×28.2×
202025.9×24.2×46.9×
201943.7×22.5×43.9×
201823.6×19.6×27.2×
201718.9×18.5×23.0×
201618.0×16.3×21.2×
201518.8×15.6×21.2×
201415.5×13.7×20.5×
201318.3×15.2×22.7×
201214.3×12.1×16.6×
201114.8×14.3×26.0×
201024.4×17.8×30.4×
200929.0×11.7×29.0×
200813.7×11.4×38.8×
200735.5×35.5×68.3×

Against its peers

Companies in Medical - Devices nearest Boston Scientific's size, closest first, today.

CompanyForward PE
BSXBoston Scientific13.4×
EWEdwards Lifesciences30.1×
GEHCGE HealthCare Technologies15.4×
SYKStryker19.4×
MDTMedtronic16.5×
DXCMDexCom30.0×
ABTAbbott Laboratories18.9×
ZBHZimmer Biometn/m
Peer median19.1×

Where Boston Scientific ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Boston Scientific

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.